<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81633">
  <stage>Registered</stage>
  <submitdate>6/10/2006</submitdate>
  <approvaldate>10/10/2006</approvaldate>
  <actrnumber>ACTRN12606000434594</actrnumber>
  <trial_identification>
    <studytitle>Vitamin D Time-Course Pilot Study</studytitle>
    <scientifictitle>Time-course of parathyroid hormone change following vitamin D supplementation in vitamin D insufficient elderly: a pilot study.</scientifictitle>
    <utrn />
    <trialacronym>Nil</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Vitamin D insufficiency</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other metabolic and endocrine disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>One of three doses of oral calciferol (Vitamin D3):
1. 500 000 iu followed by monthly placebo for 8 months.
2. 500 000 iu followed by monthly 50 000 iu for 8 months.
3. 50 000 iu monthly for 9 months.</interventions>
    <comparator>Placebo</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Time to nadir of change in parathyroid hormone</outcome>
      <timepoint>Blood measurements taken at baseline and months 1, 3, 7, and 9.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Integrated response of parathyroid hormone (area under the curve), from blood measurements</outcome>
      <timepoint>Taken at baseline and months 1, 3, 7, and 9.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Serum 25(OH)D (from blood measurements taken at baseline and months 1, 3, 7, and 9)</outcome>
      <timepoint> Taken at baseline and months 1, 3, 7, and 9.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Able to provide informed consent and have a high risk of vitamin D insufficiency.</inclusivecriteria>
    <inclusiveminage>65</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Renal insufficiency (creatinine clearance &lt; 20 ml/min).Major bone disorder, condition or drugs likely to affect calcium, parathyroid hormone or vitamin D metabolism.On high dose vitamin D or long-term steroids.Major systemic illness with a prognosis of 6 months or less.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Random allocation of participants and labelling of medications with participant number completed by individuals not involved with study participants.  Medications then administered by a study researcher who is unaware of the contents.  Participants also unaware of which dosage they have been assigned.</concealment>
    <sequence>Minimisation algorithm used to randomly assign participants to one of the three intervention groups and to ensure a balance of gender between each of the three groups.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Participants and all research staff who have contact with the participants are blinded to to allocation until all data is entered and checked.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>17/10/2005</anticipatedstartdate>
    <actualstartdate>27/10/2005</actualstartdate>
    <anticipatedenddate>21/04/2006</anticipatedenddate>
    <actualenddate>16/05/2006</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>63</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Professor I.R. Reid</primarysponsorname>
    <primarysponsoraddress>Deputy Dean
Faculty of Medical and Health Sciences
University of Auckland
Private Bag 92019
Auckland 1142</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Health Research Council of New Zealand</fundingname>
      <fundingaddress>Level 3, ProCARE Building
Grafton Mews
110 Stanley St
Auckland 1010</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Auckland Bone Research Group</sponsorname>
      <sponsoraddress>Department of Medicine
Faculty of Medical and Health Sciences
University of Auckland
Private Bag 92019
Auckland 1142</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Elderly volunteers recruited from Older Peoples Health wards at Auckland Hospital and randomly assigned to one of three active vitamin D3 treatment regimens.  Blood measurements are collected at two monthly intervals and lifestyle and body composition measurements made at baseline and at the end of the study.</summary>
    <trialwebsite />
    <publication>Bacon, C.J., Gamble, G.D., Horne, A.M., Scott, M.A. and Reid, I.R. 2009. High-dose oral vitamin D3 supplementation in the elderly. Osteoporosis International 20(8): 1407-15.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Auckland</ethicname>
      <ethicaddress />
      <ethicapprovaldate>23/09/2005</ethicapprovaldate>
      <hrec>NTX/05/09/111</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Professor I.R. Reid</name>
      <address>Deputy Dean of Faculty of Health &amp; Medical Sciences
University of Auckland
Room 2585 Building 502
Private Bag 92 019
Auckland 1020</address>
      <phone>+64 9 3737599 ext. 86259</phone>
      <fax />
      <email>i.reid@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Catherine Bacon</name>
      <address>Bone Research Group
Department of Medicine
University of Auckland
Private Bag 92 019
Auckland 1020</address>
      <phone>+64 9 3737599 ext. 89785</phone>
      <fax>+64 9 3072865</fax>
      <email>c.bacon@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>I.R. Reid</name>
      <address>Deputy Dean
Faculty of Medical and Health Sciences
University of Auckland
Private Bag 92 019
Auckland 1142</address>
      <phone>+64 9 923 6259</phone>
      <fax />
      <email>i.reid@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>